Activating mutations of the calcium-sensing receptor: The calcilytics ATF-936 and AXT-914 attenuate mutants causing autosomal dominant hypocalcemia and Bartter syndrome type 5

Authors :: E Schulze
Christof Schöfl
S Letz
K. Frank-Raue
F. Raue
B Mayr
C Haag
Source :: Experimental and Clinical Endocrinology & Diabetes. 121
Publication Year :: 2013
Publisher :: Georg Thieme Verlag KG, 2013.

Subjects :: medicine.medical_specialty
business.industry
Endocrinology, Diabetes and Metabolism
Mutant
General Medicine
Bartter syndrome
medicine.disease
Endocrinology
Internal medicine
Autosomal dominant hypocalcemia
Internal Medicine
Medicine
Calcium-sensing receptor
business

Full Text Access

Tools